TADA2A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.460600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.380200E-01
Normal-vs-Stage2
8.264400E-01
Normal-vs-Stage3
8.989000E-01
Normal-vs-Stage4
6.337400E-01
Stage1-vs-Stage2
1.583990E-01
Stage1-vs-Stage3
4.495200E-01
Stage1-vs-Stage4
9.207600E-01
Stage2-vs-Stage3
9.857400E-01
Stage2-vs-Stage4
3.051600E-01
Stage3-vs-Stage4
5.601200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.785200E-01
Normal-vs-AfricanAmerican
9.500600E-01
Normal-vs-Asian
5.000600E-01
Caucasian-vs-AfricanAmerican
8.959200E-01
Caucasian-vs-Asian
9.354200E-02
AfricanAmerican-vs-Asian
3.216400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.742800E-01
Normal-vs-Female
9.695600E-01
Male-vs-Female
4.423400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.326400E-01
Normal-vs-Age(41-60Yrs)
7.733600E-01
Normal-vs-Age(61-80Yrs)
8.190400E-01
Normal-vs-Age(81-100Yrs)
7.578000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.001200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.836400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.095600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.620300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.626400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.441800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.094800E-01
Normal-vs-Daily Drinker
4.148400E-01
Normal-vs-Weekly Drinker
7.986600E-01
Normal-vs-Occasional Drinker
6.356400E-01
Normal-vs-Social Drinker
6.612400E-01
Non Drinker-vs-Daily Drinker
5.068600E-01
Non Drinker-vs-Weekly Drinker
7.089000E-01
Non Drinker-vs-Occasional Drinker
4.481600E-02
Non Drinker-vs-Social Drinker
6.561600E-02
Daily Drinker-vs-Weekly Drinker
3.822000E-01
Daily Drinker-vs-Occasional Drinker
1.796380E-02
Daily Drinker-vs-Social Drinker
2.484500E-02
Weekly Drinker-vs-Occasional Drinker
2.060000E-01
Weekly Drinker-vs-Social Drinker
2.452600E-01
Occasional Drinker-vs-Social Drinker
8.984000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.378390E-01
Normal-vs-Grade 2
4.461500E-02
Normal-vs-Grade 3
1.602490E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.106600E-01
Grade 1-vs-Grade 3
9.543600E-01
Grade 1-vs-Grade 4
1.378390E-01
Grade 2-vs-Grade 3
3.133800E-01
Grade 2-vs-Grade 4
4.461500E-02
Grade 3-vs-Grade 4
1.602490E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.862000E-01
Normal-vs-NonDiabetic
9.529800E-01
Diabetic-vs-NonDiabetic
1.174960E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.441600E-01
Normal-vs-NoPancreatitis
8.490000E-01
Pancreatitis-vs-NoPancreatitis
8.073800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.283600E-01
Normal-vs-N1
8.594000E-01
N0-vs-N1
3.503200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.842400E-01
Normal-vs-TP53-NonMutant
7.440800E-01
TP53-Mutant-vs-TP53-NonMutant
2.281200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
